Tracker / Company

United Therapeutics

2 entries Most recent disclosure: Last verified:

Diagnostics and clinical decision support

Machine-learning prediction of lung-transplant acceptance during rc-EVLP

Announcement

At ISHLT 2026, United Therapeutics listed a presentation from its ex-vivo lung perfusion program on using machine learning for earlier, real-time predictions of whether a lung will be accepted for transplant during rc-EVLP.

Company Archive pending Verified: Permalink

Tempus collaboration on pulmonary hypertension identification

Announcement

United Therapeutics unveiled preliminary findings from its collaboration with Tempus, which it describes as a leader in artificial intelligence and precision medicine, laying the foundation for earlier identification of patients with pulmonary hypertension.

Partners: Tempus

Company Archive pending Verified: Permalink